| Period Ending: |
LTM
(Last Twelve Months) |
2025 12-31 |
2024 12-31 |
2023 12-31 |
|---|---|---|---|---|
| Report Filing | 2026-03-10 | 2026-03-10 | 2024-12-31 | 2023-12-31 |
| Revenue | 47.32 | 47.32 | 31.62 | 19.27 |
| Cost of Revenue | 11.12 | 11.12 | 7.28 | 4 |
| Gross Profit | 36.2 | 36.2 | 24.34 | 15.27 |
| Operating Expenses | 62.5 | 62.5 | 38.99 | 26.13 |
| Research & Development | 7.73 | 7.73 | 4.49 | 3.02 |
| Selling, General and Administrative | 54.77 | 54.77 | 34.51 | 23.11 |
| Other Operating Expenses | 0 | 0 | 0 | 0 |
| Operating Income | -26.3 | -26.3 | -14.65 | -10.86 |
| Net Non-Operating Interest | -0.07 | -0.07 | -1.32 | -0.761 |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0.07 | 0.07 | 1.32 | 0.761 |
| Equity & Other Income/(Expense) | -13.99 | -13.99 | 0.35 | -1.03 |
| Income Before Tax | -40.36 | -40.36 | -15.62 | -12.65 |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 |
| Net Income | -40.36 | -40.36 | -15.62 | -12.65 |
| Depreciation and Amortization | 2.23 | 0 | 2.2 | 1.64 |
| EBITDA | -24.07 | -26.3 | -12.46 | -9.22 |
| Earnings Per Share (EPS) | -1.62 | -0.005 | -0.77 | -0.63 |
| Diluted Earnings Per Share | -1.62 | -0.005 | -0.77 | -0.63 |
| Weighted Average Shares Outstanding | 20.6 | 8,673 | 20.23 | 20.23 |
| Diluted Weighted Average Shares Outstanding | 20.6 | 8,673 | 20.23 | 20.23 |
